Molecular basis for the deficiency of complement 1 inhibitor in type I hereditary angioneurotic edema.

M Cicardi, T Igarashi, FS Rosen… - The Journal of clinical …, 1987 - Am Soc Clin Investig
M Cicardi, T Igarashi, FS Rosen, AE Davis
The Journal of clinical investigation, 1987Am Soc Clin Investig
Hereditary angioneurotic edema (HANE) results from deficiency of complement 1 inhibitor
(C1 INH). In type I HANE, C1 INH is present in serum at levels 5-30% of normals. Using
cultured monocytes and biosynthetic labeling of proteins, C1 INH was detected in
supernatants of cells from HANE patients at levels 20% of those detected in normals. The
intracellular reduction of C1 INH in patients' monocytes approached 50%. The study of C1
INH messenger RNA (mRNA) by Northern blot analysis indicated that in HANE patients' …
Hereditary angioneurotic edema (HANE) results from deficiency of complement 1 inhibitor (C1 INH). In type I HANE, C1 INH is present in serum at levels 5-30% of normals. Using cultured monocytes and biosynthetic labeling of proteins, C1 INH was detected in supernatants of cells from HANE patients at levels 20% of those detected in normals. The intracellular reduction of C1 INH in patients' monocytes approached 50%. The study of C1 INH messenger RNA (mRNA) by Northern blot analysis indicated that in HANE patients' monocytes a message of normal size is present at about half the concentration of that from normal cells. One of the patients analyzed showed the presence of a genetically inherited abnormal mRNA (1.9 kb) in addition to the normal mRNA (2.1 kb). Southern blot analysis of DNA from peripheral blood leukocytes did not show any difference in quantity or in sizes of endonuclease restriction fragments between patients and normals. The defect(s), therefore, in type I HANE is pretranslational, but is not due to a deletion or to a major chromosomal rearrangement.
Images
The Journal of Clinical Investigation